Global RNA Interference Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global RNA Interference Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
RNA Interference Therapy, or RNAi Therapy, is a cutting-edge medical approach that utilizes small RNA molecules to selectively silence or regulate targeted genes. This therapeutic method involves introducing synthetic small interfering RNA (siRNA) or microRNA (miRNA) into cells, triggering a natural biological process that inhibits the expression of disease-related genes. RNA Interference Therapy shows promise in treating various conditions, including genetic disorders, viral infections, and certain cancers. By leveraging the specificity of RNA molecules, this therapy holds the potential to revolutionize precision medicine by addressing the root causes of diseases at the genetic level, promoting targeted and personalized treatment strategies.
The RNA Interference Therapy industry is experiencing a dynamic shift towards precision medicine and targeted treatments. Advancements in understanding genetic mechanisms have fueled a surge in RNAi research and development. The trend emphasizes personalized therapies, with a focus on tackling specific gene-related disorders at the molecular level. Improvements in delivery systems, such as nanoparticle technologies, are enhancing the efficiency and specificity of RNA interference. The growing pipeline of RNAi-based drug candidates, especially in oncology and rare diseases, showcases the increasing interest and investment in this therapeutic approach. Overall, the industry trend leans towards unlocking the full potential of RNA Interference Therapy for precise and effective medical interventions.
The Global Info Research report includes an overview of the development of the RNA Interference Therapy industry chain, the market status of Cancer Treatment (siRNA, miRNA), Hereditary Disease (siRNA, miRNA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of RNA Interference Therapy.
Regionally, the report analyzes the RNA Interference Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global RNA Interference Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the RNA Interference Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the RNA Interference Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., siRNA, miRNA).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the RNA Interference Therapy market.
Regional Analysis: The report involves examining the RNA Interference Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the RNA Interference Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to RNA Interference Therapy:
Company Analysis: Report covers individual RNA Interference Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards RNA Interference Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer Treatment, Hereditary Disease).
Technology Analysis: Report covers specific technologies relevant to RNA Interference Therapy. It assesses the current state, advancements, and potential future developments in RNA Interference Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the RNA Interference Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
RNA Interference Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe RNA Interference Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNA Interference Therapy, with revenue, gross margin and global market share of RNA Interference Therapy from 2019 to 2024.
Chapter 3, the RNA Interference Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and RNA Interference Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Interference Therapy.
Chapter 13, to describe RNA Interference Therapy research findings and conclusion.
RNA Interference Therapy, or RNAi Therapy, is a cutting-edge medical approach that utilizes small RNA molecules to selectively silence or regulate targeted genes. This therapeutic method involves introducing synthetic small interfering RNA (siRNA) or microRNA (miRNA) into cells, triggering a natural biological process that inhibits the expression of disease-related genes. RNA Interference Therapy shows promise in treating various conditions, including genetic disorders, viral infections, and certain cancers. By leveraging the specificity of RNA molecules, this therapy holds the potential to revolutionize precision medicine by addressing the root causes of diseases at the genetic level, promoting targeted and personalized treatment strategies.
The RNA Interference Therapy industry is experiencing a dynamic shift towards precision medicine and targeted treatments. Advancements in understanding genetic mechanisms have fueled a surge in RNAi research and development. The trend emphasizes personalized therapies, with a focus on tackling specific gene-related disorders at the molecular level. Improvements in delivery systems, such as nanoparticle technologies, are enhancing the efficiency and specificity of RNA interference. The growing pipeline of RNAi-based drug candidates, especially in oncology and rare diseases, showcases the increasing interest and investment in this therapeutic approach. Overall, the industry trend leans towards unlocking the full potential of RNA Interference Therapy for precise and effective medical interventions.
The Global Info Research report includes an overview of the development of the RNA Interference Therapy industry chain, the market status of Cancer Treatment (siRNA, miRNA), Hereditary Disease (siRNA, miRNA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of RNA Interference Therapy.
Regionally, the report analyzes the RNA Interference Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global RNA Interference Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the RNA Interference Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the RNA Interference Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., siRNA, miRNA).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the RNA Interference Therapy market.
Regional Analysis: The report involves examining the RNA Interference Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the RNA Interference Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to RNA Interference Therapy:
Company Analysis: Report covers individual RNA Interference Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards RNA Interference Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer Treatment, Hereditary Disease).
Technology Analysis: Report covers specific technologies relevant to RNA Interference Therapy. It assesses the current state, advancements, and potential future developments in RNA Interference Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the RNA Interference Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
RNA Interference Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- siRNA
- miRNA
- shRNA
- piRNA
- Cancer Treatment
- Hereditary Disease
- Infectious Disease
- Nervous System Disease
- Diseases of Immune System
- Cardiovascular Disease
- Metabolic Disease
- Silence Therapeutics
- Arrowhead Pharmaceuticals
- Janssen Research & Development
- Sylentis
- Sirnaomics
- Dicerna Pharmaceuticals
- Alnylam Pharmaceuticals
- Silenseed
- Vir Biotechnology
- OliX Pharmaceuticals
- Bio-Path Holdings
- Suzhou Ribo Life Science
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe RNA Interference Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNA Interference Therapy, with revenue, gross margin and global market share of RNA Interference Therapy from 2019 to 2024.
Chapter 3, the RNA Interference Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and RNA Interference Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Interference Therapy.
Chapter 13, to describe RNA Interference Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of RNA Interference Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of RNA Interference Therapy by Type
1.3.1 Overview: Global RNA Interference Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global RNA Interference Therapy Consumption Value Market Share by Type in 2023
1.3.3 siRNA
1.3.4 miRNA
1.3.5 shRNA
1.3.6 piRNA
1.4 Global RNA Interference Therapy Market by Application
1.4.1 Overview: Global RNA Interference Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer Treatment
1.4.3 Hereditary Disease
1.4.4 Infectious Disease
1.4.5 Nervous System Disease
1.4.6 Diseases of Immune System
1.4.7 Cardiovascular Disease
1.4.8 Metabolic Disease
1.5 Global RNA Interference Therapy Market Size & Forecast
1.6 Global RNA Interference Therapy Market Size and Forecast by Region
1.6.1 Global RNA Interference Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global RNA Interference Therapy Market Size by Region, (2019-2030)
1.6.3 North America RNA Interference Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe RNA Interference Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific RNA Interference Therapy Market Size and Prospect (2019-2030)
1.6.6 South America RNA Interference Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa RNA Interference Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Silence Therapeutics
2.1.1 Silence Therapeutics Details
2.1.2 Silence Therapeutics Major Business
2.1.3 Silence Therapeutics RNA Interference Therapy Product and Solutions
2.1.4 Silence Therapeutics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Silence Therapeutics Recent Developments and Future Plans
2.2 Arrowhead Pharmaceuticals
2.2.1 Arrowhead Pharmaceuticals Details
2.2.2 Arrowhead Pharmaceuticals Major Business
2.2.3 Arrowhead Pharmaceuticals RNA Interference Therapy Product and Solutions
2.2.4 Arrowhead Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Arrowhead Pharmaceuticals Recent Developments and Future Plans
2.3 Janssen Research & Development
2.3.1 Janssen Research & Development Details
2.3.2 Janssen Research & Development Major Business
2.3.3 Janssen Research & Development RNA Interference Therapy Product and Solutions
2.3.4 Janssen Research & Development RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Janssen Research & Development Recent Developments and Future Plans
2.4 Sylentis
2.4.1 Sylentis Details
2.4.2 Sylentis Major Business
2.4.3 Sylentis RNA Interference Therapy Product and Solutions
2.4.4 Sylentis RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sylentis Recent Developments and Future Plans
2.5 Sirnaomics
2.5.1 Sirnaomics Details
2.5.2 Sirnaomics Major Business
2.5.3 Sirnaomics RNA Interference Therapy Product and Solutions
2.5.4 Sirnaomics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sirnaomics Recent Developments and Future Plans
2.6 Dicerna Pharmaceuticals
2.6.1 Dicerna Pharmaceuticals Details
2.6.2 Dicerna Pharmaceuticals Major Business
2.6.3 Dicerna Pharmaceuticals RNA Interference Therapy Product and Solutions
2.6.4 Dicerna Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dicerna Pharmaceuticals Recent Developments and Future Plans
2.7 Alnylam Pharmaceuticals
2.7.1 Alnylam Pharmaceuticals Details
2.7.2 Alnylam Pharmaceuticals Major Business
2.7.3 Alnylam Pharmaceuticals RNA Interference Therapy Product and Solutions
2.7.4 Alnylam Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.8 Silenseed
2.8.1 Silenseed Details
2.8.2 Silenseed Major Business
2.8.3 Silenseed RNA Interference Therapy Product and Solutions
2.8.4 Silenseed RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Silenseed Recent Developments and Future Plans
2.9 Vir Biotechnology
2.9.1 Vir Biotechnology Details
2.9.2 Vir Biotechnology Major Business
2.9.3 Vir Biotechnology RNA Interference Therapy Product and Solutions
2.9.4 Vir Biotechnology RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Vir Biotechnology Recent Developments and Future Plans
2.10 OliX Pharmaceuticals
2.10.1 OliX Pharmaceuticals Details
2.10.2 OliX Pharmaceuticals Major Business
2.10.3 OliX Pharmaceuticals RNA Interference Therapy Product and Solutions
2.10.4 OliX Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 OliX Pharmaceuticals Recent Developments and Future Plans
2.11 Bio-Path Holdings
2.11.1 Bio-Path Holdings Details
2.11.2 Bio-Path Holdings Major Business
2.11.3 Bio-Path Holdings RNA Interference Therapy Product and Solutions
2.11.4 Bio-Path Holdings RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bio-Path Holdings Recent Developments and Future Plans
2.12 Suzhou Ribo Life Science
2.12.1 Suzhou Ribo Life Science Details
2.12.2 Suzhou Ribo Life Science Major Business
2.12.3 Suzhou Ribo Life Science RNA Interference Therapy Product and Solutions
2.12.4 Suzhou Ribo Life Science RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Suzhou Ribo Life Science Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global RNA Interference Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of RNA Interference Therapy by Company Revenue
3.2.2 Top 3 RNA Interference Therapy Players Market Share in 2023
3.2.3 Top 6 RNA Interference Therapy Players Market Share in 2023
3.3 RNA Interference Therapy Market: Overall Company Footprint Analysis
3.3.1 RNA Interference Therapy Market: Region Footprint
3.3.2 RNA Interference Therapy Market: Company Product Type Footprint
3.3.3 RNA Interference Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global RNA Interference Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global RNA Interference Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global RNA Interference Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global RNA Interference Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America RNA Interference Therapy Consumption Value by Type (2019-2030)
6.2 North America RNA Interference Therapy Consumption Value by Application (2019-2030)
6.3 North America RNA Interference Therapy Market Size by Country
6.3.1 North America RNA Interference Therapy Consumption Value by Country (2019-2030)
6.3.2 United States RNA Interference Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada RNA Interference Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico RNA Interference Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe RNA Interference Therapy Consumption Value by Type (2019-2030)
7.2 Europe RNA Interference Therapy Consumption Value by Application (2019-2030)
7.3 Europe RNA Interference Therapy Market Size by Country
7.3.1 Europe RNA Interference Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany RNA Interference Therapy Market Size and Forecast (2019-2030)
7.3.3 France RNA Interference Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom RNA Interference Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia RNA Interference Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy RNA Interference Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific RNA Interference Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific RNA Interference Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific RNA Interference Therapy Market Size by Region
8.3.1 Asia-Pacific RNA Interference Therapy Consumption Value by Region (2019-2030)
8.3.2 China RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.5 India RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia RNA Interference Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America RNA Interference Therapy Consumption Value by Type (2019-2030)
9.2 South America RNA Interference Therapy Consumption Value by Application (2019-2030)
9.3 South America RNA Interference Therapy Market Size by Country
9.3.1 South America RNA Interference Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil RNA Interference Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina RNA Interference Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa RNA Interference Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa RNA Interference Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa RNA Interference Therapy Market Size by Country
10.3.1 Middle East & Africa RNA Interference Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey RNA Interference Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia RNA Interference Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE RNA Interference Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 RNA Interference Therapy Market Drivers
11.2 RNA Interference Therapy Market Restraints
11.3 RNA Interference Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 RNA Interference Therapy Industry Chain
12.2 RNA Interference Therapy Upstream Analysis
12.3 RNA Interference Therapy Midstream Analysis
12.4 RNA Interference Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of RNA Interference Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of RNA Interference Therapy by Type
1.3.1 Overview: Global RNA Interference Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global RNA Interference Therapy Consumption Value Market Share by Type in 2023
1.3.3 siRNA
1.3.4 miRNA
1.3.5 shRNA
1.3.6 piRNA
1.4 Global RNA Interference Therapy Market by Application
1.4.1 Overview: Global RNA Interference Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer Treatment
1.4.3 Hereditary Disease
1.4.4 Infectious Disease
1.4.5 Nervous System Disease
1.4.6 Diseases of Immune System
1.4.7 Cardiovascular Disease
1.4.8 Metabolic Disease
1.5 Global RNA Interference Therapy Market Size & Forecast
1.6 Global RNA Interference Therapy Market Size and Forecast by Region
1.6.1 Global RNA Interference Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global RNA Interference Therapy Market Size by Region, (2019-2030)
1.6.3 North America RNA Interference Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe RNA Interference Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific RNA Interference Therapy Market Size and Prospect (2019-2030)
1.6.6 South America RNA Interference Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa RNA Interference Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Silence Therapeutics
2.1.1 Silence Therapeutics Details
2.1.2 Silence Therapeutics Major Business
2.1.3 Silence Therapeutics RNA Interference Therapy Product and Solutions
2.1.4 Silence Therapeutics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Silence Therapeutics Recent Developments and Future Plans
2.2 Arrowhead Pharmaceuticals
2.2.1 Arrowhead Pharmaceuticals Details
2.2.2 Arrowhead Pharmaceuticals Major Business
2.2.3 Arrowhead Pharmaceuticals RNA Interference Therapy Product and Solutions
2.2.4 Arrowhead Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Arrowhead Pharmaceuticals Recent Developments and Future Plans
2.3 Janssen Research & Development
2.3.1 Janssen Research & Development Details
2.3.2 Janssen Research & Development Major Business
2.3.3 Janssen Research & Development RNA Interference Therapy Product and Solutions
2.3.4 Janssen Research & Development RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Janssen Research & Development Recent Developments and Future Plans
2.4 Sylentis
2.4.1 Sylentis Details
2.4.2 Sylentis Major Business
2.4.3 Sylentis RNA Interference Therapy Product and Solutions
2.4.4 Sylentis RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sylentis Recent Developments and Future Plans
2.5 Sirnaomics
2.5.1 Sirnaomics Details
2.5.2 Sirnaomics Major Business
2.5.3 Sirnaomics RNA Interference Therapy Product and Solutions
2.5.4 Sirnaomics RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sirnaomics Recent Developments and Future Plans
2.6 Dicerna Pharmaceuticals
2.6.1 Dicerna Pharmaceuticals Details
2.6.2 Dicerna Pharmaceuticals Major Business
2.6.3 Dicerna Pharmaceuticals RNA Interference Therapy Product and Solutions
2.6.4 Dicerna Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dicerna Pharmaceuticals Recent Developments and Future Plans
2.7 Alnylam Pharmaceuticals
2.7.1 Alnylam Pharmaceuticals Details
2.7.2 Alnylam Pharmaceuticals Major Business
2.7.3 Alnylam Pharmaceuticals RNA Interference Therapy Product and Solutions
2.7.4 Alnylam Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.8 Silenseed
2.8.1 Silenseed Details
2.8.2 Silenseed Major Business
2.8.3 Silenseed RNA Interference Therapy Product and Solutions
2.8.4 Silenseed RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Silenseed Recent Developments and Future Plans
2.9 Vir Biotechnology
2.9.1 Vir Biotechnology Details
2.9.2 Vir Biotechnology Major Business
2.9.3 Vir Biotechnology RNA Interference Therapy Product and Solutions
2.9.4 Vir Biotechnology RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Vir Biotechnology Recent Developments and Future Plans
2.10 OliX Pharmaceuticals
2.10.1 OliX Pharmaceuticals Details
2.10.2 OliX Pharmaceuticals Major Business
2.10.3 OliX Pharmaceuticals RNA Interference Therapy Product and Solutions
2.10.4 OliX Pharmaceuticals RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 OliX Pharmaceuticals Recent Developments and Future Plans
2.11 Bio-Path Holdings
2.11.1 Bio-Path Holdings Details
2.11.2 Bio-Path Holdings Major Business
2.11.3 Bio-Path Holdings RNA Interference Therapy Product and Solutions
2.11.4 Bio-Path Holdings RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bio-Path Holdings Recent Developments and Future Plans
2.12 Suzhou Ribo Life Science
2.12.1 Suzhou Ribo Life Science Details
2.12.2 Suzhou Ribo Life Science Major Business
2.12.3 Suzhou Ribo Life Science RNA Interference Therapy Product and Solutions
2.12.4 Suzhou Ribo Life Science RNA Interference Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Suzhou Ribo Life Science Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global RNA Interference Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of RNA Interference Therapy by Company Revenue
3.2.2 Top 3 RNA Interference Therapy Players Market Share in 2023
3.2.3 Top 6 RNA Interference Therapy Players Market Share in 2023
3.3 RNA Interference Therapy Market: Overall Company Footprint Analysis
3.3.1 RNA Interference Therapy Market: Region Footprint
3.3.2 RNA Interference Therapy Market: Company Product Type Footprint
3.3.3 RNA Interference Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global RNA Interference Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global RNA Interference Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global RNA Interference Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global RNA Interference Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America RNA Interference Therapy Consumption Value by Type (2019-2030)
6.2 North America RNA Interference Therapy Consumption Value by Application (2019-2030)
6.3 North America RNA Interference Therapy Market Size by Country
6.3.1 North America RNA Interference Therapy Consumption Value by Country (2019-2030)
6.3.2 United States RNA Interference Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada RNA Interference Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico RNA Interference Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe RNA Interference Therapy Consumption Value by Type (2019-2030)
7.2 Europe RNA Interference Therapy Consumption Value by Application (2019-2030)
7.3 Europe RNA Interference Therapy Market Size by Country
7.3.1 Europe RNA Interference Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany RNA Interference Therapy Market Size and Forecast (2019-2030)
7.3.3 France RNA Interference Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom RNA Interference Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia RNA Interference Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy RNA Interference Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific RNA Interference Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific RNA Interference Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific RNA Interference Therapy Market Size by Region
8.3.1 Asia-Pacific RNA Interference Therapy Consumption Value by Region (2019-2030)
8.3.2 China RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.5 India RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia RNA Interference Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia RNA Interference Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America RNA Interference Therapy Consumption Value by Type (2019-2030)
9.2 South America RNA Interference Therapy Consumption Value by Application (2019-2030)
9.3 South America RNA Interference Therapy Market Size by Country
9.3.1 South America RNA Interference Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil RNA Interference Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina RNA Interference Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa RNA Interference Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa RNA Interference Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa RNA Interference Therapy Market Size by Country
10.3.1 Middle East & Africa RNA Interference Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey RNA Interference Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia RNA Interference Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE RNA Interference Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 RNA Interference Therapy Market Drivers
11.2 RNA Interference Therapy Market Restraints
11.3 RNA Interference Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 RNA Interference Therapy Industry Chain
12.2 RNA Interference Therapy Upstream Analysis
12.3 RNA Interference Therapy Midstream Analysis
12.4 RNA Interference Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
.
Table 1. Global RNA Interference Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global RNA Interference Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global RNA Interference Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global RNA Interference Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Silence Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Silence Therapeutics Major Business
Table 7. Silence Therapeutics RNA Interference Therapy Product and Solutions
Table 8. Silence Therapeutics RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Silence Therapeutics Recent Developments and Future Plans
Table 10. Arrowhead Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Arrowhead Pharmaceuticals Major Business
Table 12. Arrowhead Pharmaceuticals RNA Interference Therapy Product and Solutions
Table 13. Arrowhead Pharmaceuticals RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Arrowhead Pharmaceuticals Recent Developments and Future Plans
Table 15. Janssen Research & Development Company Information, Head Office, and Major Competitors
Table 16. Janssen Research & Development Major Business
Table 17. Janssen Research & Development RNA Interference Therapy Product and Solutions
Table 18. Janssen Research & Development RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Janssen Research & Development Recent Developments and Future Plans
Table 20. Sylentis Company Information, Head Office, and Major Competitors
Table 21. Sylentis Major Business
Table 22. Sylentis RNA Interference Therapy Product and Solutions
Table 23. Sylentis RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Sylentis Recent Developments and Future Plans
Table 25. Sirnaomics Company Information, Head Office, and Major Competitors
Table 26. Sirnaomics Major Business
Table 27. Sirnaomics RNA Interference Therapy Product and Solutions
Table 28. Sirnaomics RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sirnaomics Recent Developments and Future Plans
Table 30. Dicerna Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. Dicerna Pharmaceuticals Major Business
Table 32. Dicerna Pharmaceuticals RNA Interference Therapy Product and Solutions
Table 33. Dicerna Pharmaceuticals RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Dicerna Pharmaceuticals Recent Developments and Future Plans
Table 35. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Alnylam Pharmaceuticals Major Business
Table 37. Alnylam Pharmaceuticals RNA Interference Therapy Product and Solutions
Table 38. Alnylam Pharmaceuticals RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 40. Silenseed Company Information, Head Office, and Major Competitors
Table 41. Silenseed Major Business
Table 42. Silenseed RNA Interference Therapy Product and Solutions
Table 43. Silenseed RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Silenseed Recent Developments and Future Plans
Table 45. Vir Biotechnology Company Information, Head Office, and Major Competitors
Table 46. Vir Biotechnology Major Business
Table 47. Vir Biotechnology RNA Interference Therapy Product and Solutions
Table 48. Vir Biotechnology RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Vir Biotechnology Recent Developments and Future Plans
Table 50. OliX Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. OliX Pharmaceuticals Major Business
Table 52. OliX Pharmaceuticals RNA Interference Therapy Product and Solutions
Table 53. OliX Pharmaceuticals RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. OliX Pharmaceuticals Recent Developments and Future Plans
Table 55. Bio-Path Holdings Company Information, Head Office, and Major Competitors
Table 56. Bio-Path Holdings Major Business
Table 57. Bio-Path Holdings RNA Interference Therapy Product and Solutions
Table 58. Bio-Path Holdings RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Bio-Path Holdings Recent Developments and Future Plans
Table 60. Suzhou Ribo Life Science Company Information, Head Office, and Major Competitors
Table 61. Suzhou Ribo Life Science Major Business
Table 62. Suzhou Ribo Life Science RNA Interference Therapy Product and Solutions
Table 63. Suzhou Ribo Life Science RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Suzhou Ribo Life Science Recent Developments and Future Plans
Table 65. Global RNA Interference Therapy Revenue (USD Million) by Players (2019-2024)
Table 66. Global RNA Interference Therapy Revenue Share by Players (2019-2024)
Table 67. Breakdown of RNA Interference Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in RNA Interference Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key RNA Interference Therapy Players
Table 70. RNA Interference Therapy Market: Company Product Type Footprint
Table 71. RNA Interference Therapy Market: Company Product Application Footprint
Table 72. RNA Interference Therapy New Market Entrants and Barriers to Market Entry
Table 73. RNA Interference Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global RNA Interference Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global RNA Interference Therapy Consumption Value Share by Type (2019-2024)
Table 76. Global RNA Interference Therapy Consumption Value Forecast by Type (2025-2030)
Table 77. Global RNA Interference Therapy Consumption Value by Application (2019-2024)
Table 78. Global RNA Interference Therapy Consumption Value Forecast by Application (2025-2030)
Table 79. North America RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America RNA Interference Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America RNA Interference Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe RNA Interference Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe RNA Interference Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific RNA Interference Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific RNA Interference Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America RNA Interference Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America RNA Interference Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa RNA Interference Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa RNA Interference Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 109. RNA Interference Therapy Raw Material
Table 110. Key Suppliers of RNA Interference Therapy Raw Materials
LIST OF FIGURE
. s
Figure 1. RNA Interference Therapy Picture
Figure 2. Global RNA Interference Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global RNA Interference Therapy Consumption Value Market Share by Type in 2023
Figure 4. siRNA
Figure 5. miRNA
Figure 6. shRNA
Figure 7. piRNA
Figure 8. Global RNA Interference Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. RNA Interference Therapy Consumption Value Market Share by Application in 2023
Figure 10. Cancer Treatment Picture
Figure 11. Hereditary Disease Picture
Figure 12. Infectious Disease Picture
Figure 13. Nervous System Disease Picture
Figure 14. Diseases of Immune System Picture
Figure 15. Cardiovascular Disease Picture
Figure 16. Metabolic Disease Picture
Figure 17. Global RNA Interference Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global RNA Interference Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market RNA Interference Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global RNA Interference Therapy Consumption Value Market Share by Region (2019-2030)
Figure 21. Global RNA Interference Therapy Consumption Value Market Share by Region in 2023
Figure 22. North America RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 25. South America RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 27. Global RNA Interference Therapy Revenue Share by Players in 2023
Figure 28. RNA Interference Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players RNA Interference Therapy Market Share in 2023
Figure 30. Global Top 6 Players RNA Interference Therapy Market Share in 2023
Figure 31. Global RNA Interference Therapy Consumption Value Share by Type (2019-2024)
Figure 32. Global RNA Interference Therapy Market Share Forecast by Type (2025-2030)
Figure 33. Global RNA Interference Therapy Consumption Value Share by Application (2019-2024)
Figure 34. Global RNA Interference Therapy Market Share Forecast by Application (2025-2030)
Figure 35. North America RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 36. North America RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 37. North America RNA Interference Therapy Consumption Value Market Share by Country (2019-2030)
Figure 38. United States RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe RNA Interference Therapy Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 45. France RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific RNA Interference Therapy Consumption Value Market Share by Region (2019-2030)
Figure 52. China RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 55. India RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. South America RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 59. South America RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 60. South America RNA Interference Therapy Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa RNA Interference Therapy Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 69. RNA Interference Therapy Market Drivers
Figure 70. RNA Interference Therapy Market Restraints
Figure 71. RNA Interference Therapy Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of RNA Interference Therapy in 2023
Figure 74. Manufacturing Process Analysis of RNA Interference Therapy
Figure 75. RNA Interference Therapy Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
.
Table 1. Global RNA Interference Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global RNA Interference Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global RNA Interference Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global RNA Interference Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Silence Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Silence Therapeutics Major Business
Table 7. Silence Therapeutics RNA Interference Therapy Product and Solutions
Table 8. Silence Therapeutics RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Silence Therapeutics Recent Developments and Future Plans
Table 10. Arrowhead Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Arrowhead Pharmaceuticals Major Business
Table 12. Arrowhead Pharmaceuticals RNA Interference Therapy Product and Solutions
Table 13. Arrowhead Pharmaceuticals RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Arrowhead Pharmaceuticals Recent Developments and Future Plans
Table 15. Janssen Research & Development Company Information, Head Office, and Major Competitors
Table 16. Janssen Research & Development Major Business
Table 17. Janssen Research & Development RNA Interference Therapy Product and Solutions
Table 18. Janssen Research & Development RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Janssen Research & Development Recent Developments and Future Plans
Table 20. Sylentis Company Information, Head Office, and Major Competitors
Table 21. Sylentis Major Business
Table 22. Sylentis RNA Interference Therapy Product and Solutions
Table 23. Sylentis RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Sylentis Recent Developments and Future Plans
Table 25. Sirnaomics Company Information, Head Office, and Major Competitors
Table 26. Sirnaomics Major Business
Table 27. Sirnaomics RNA Interference Therapy Product and Solutions
Table 28. Sirnaomics RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sirnaomics Recent Developments and Future Plans
Table 30. Dicerna Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. Dicerna Pharmaceuticals Major Business
Table 32. Dicerna Pharmaceuticals RNA Interference Therapy Product and Solutions
Table 33. Dicerna Pharmaceuticals RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Dicerna Pharmaceuticals Recent Developments and Future Plans
Table 35. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Alnylam Pharmaceuticals Major Business
Table 37. Alnylam Pharmaceuticals RNA Interference Therapy Product and Solutions
Table 38. Alnylam Pharmaceuticals RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 40. Silenseed Company Information, Head Office, and Major Competitors
Table 41. Silenseed Major Business
Table 42. Silenseed RNA Interference Therapy Product and Solutions
Table 43. Silenseed RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Silenseed Recent Developments and Future Plans
Table 45. Vir Biotechnology Company Information, Head Office, and Major Competitors
Table 46. Vir Biotechnology Major Business
Table 47. Vir Biotechnology RNA Interference Therapy Product and Solutions
Table 48. Vir Biotechnology RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Vir Biotechnology Recent Developments and Future Plans
Table 50. OliX Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. OliX Pharmaceuticals Major Business
Table 52. OliX Pharmaceuticals RNA Interference Therapy Product and Solutions
Table 53. OliX Pharmaceuticals RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. OliX Pharmaceuticals Recent Developments and Future Plans
Table 55. Bio-Path Holdings Company Information, Head Office, and Major Competitors
Table 56. Bio-Path Holdings Major Business
Table 57. Bio-Path Holdings RNA Interference Therapy Product and Solutions
Table 58. Bio-Path Holdings RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Bio-Path Holdings Recent Developments and Future Plans
Table 60. Suzhou Ribo Life Science Company Information, Head Office, and Major Competitors
Table 61. Suzhou Ribo Life Science Major Business
Table 62. Suzhou Ribo Life Science RNA Interference Therapy Product and Solutions
Table 63. Suzhou Ribo Life Science RNA Interference Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Suzhou Ribo Life Science Recent Developments and Future Plans
Table 65. Global RNA Interference Therapy Revenue (USD Million) by Players (2019-2024)
Table 66. Global RNA Interference Therapy Revenue Share by Players (2019-2024)
Table 67. Breakdown of RNA Interference Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in RNA Interference Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key RNA Interference Therapy Players
Table 70. RNA Interference Therapy Market: Company Product Type Footprint
Table 71. RNA Interference Therapy Market: Company Product Application Footprint
Table 72. RNA Interference Therapy New Market Entrants and Barriers to Market Entry
Table 73. RNA Interference Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global RNA Interference Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global RNA Interference Therapy Consumption Value Share by Type (2019-2024)
Table 76. Global RNA Interference Therapy Consumption Value Forecast by Type (2025-2030)
Table 77. Global RNA Interference Therapy Consumption Value by Application (2019-2024)
Table 78. Global RNA Interference Therapy Consumption Value Forecast by Application (2025-2030)
Table 79. North America RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America RNA Interference Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America RNA Interference Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe RNA Interference Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe RNA Interference Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific RNA Interference Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific RNA Interference Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America RNA Interference Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America RNA Interference Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa RNA Interference Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa RNA Interference Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa RNA Interference Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa RNA Interference Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa RNA Interference Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa RNA Interference Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 109. RNA Interference Therapy Raw Material
Table 110. Key Suppliers of RNA Interference Therapy Raw Materials
LIST OF FIGURE
. s
Figure 1. RNA Interference Therapy Picture
Figure 2. Global RNA Interference Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global RNA Interference Therapy Consumption Value Market Share by Type in 2023
Figure 4. siRNA
Figure 5. miRNA
Figure 6. shRNA
Figure 7. piRNA
Figure 8. Global RNA Interference Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. RNA Interference Therapy Consumption Value Market Share by Application in 2023
Figure 10. Cancer Treatment Picture
Figure 11. Hereditary Disease Picture
Figure 12. Infectious Disease Picture
Figure 13. Nervous System Disease Picture
Figure 14. Diseases of Immune System Picture
Figure 15. Cardiovascular Disease Picture
Figure 16. Metabolic Disease Picture
Figure 17. Global RNA Interference Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global RNA Interference Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market RNA Interference Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global RNA Interference Therapy Consumption Value Market Share by Region (2019-2030)
Figure 21. Global RNA Interference Therapy Consumption Value Market Share by Region in 2023
Figure 22. North America RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 25. South America RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 27. Global RNA Interference Therapy Revenue Share by Players in 2023
Figure 28. RNA Interference Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players RNA Interference Therapy Market Share in 2023
Figure 30. Global Top 6 Players RNA Interference Therapy Market Share in 2023
Figure 31. Global RNA Interference Therapy Consumption Value Share by Type (2019-2024)
Figure 32. Global RNA Interference Therapy Market Share Forecast by Type (2025-2030)
Figure 33. Global RNA Interference Therapy Consumption Value Share by Application (2019-2024)
Figure 34. Global RNA Interference Therapy Market Share Forecast by Application (2025-2030)
Figure 35. North America RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 36. North America RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 37. North America RNA Interference Therapy Consumption Value Market Share by Country (2019-2030)
Figure 38. United States RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe RNA Interference Therapy Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 45. France RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific RNA Interference Therapy Consumption Value Market Share by Region (2019-2030)
Figure 52. China RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 55. India RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. South America RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 59. South America RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 60. South America RNA Interference Therapy Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa RNA Interference Therapy Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa RNA Interference Therapy Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa RNA Interference Therapy Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE RNA Interference Therapy Consumption Value (2019-2030) & (USD Million)
Figure 69. RNA Interference Therapy Market Drivers
Figure 70. RNA Interference Therapy Market Restraints
Figure 71. RNA Interference Therapy Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of RNA Interference Therapy in 2023
Figure 74. Manufacturing Process Analysis of RNA Interference Therapy
Figure 75. RNA Interference Therapy Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
